Abstract |
Seventy-three patients with superficial lymph node tuberculosis, who received either 9 months' or 18 months' treatment with rifampicin and isoniazid, supplemented by ethambutol for the first 8 weeks, were followed up for 5 years. No clinical nor microbiological relapse was recorded. The cosmetic results were good in both groups. Initial surgery or aspiration conferred no advantage or disadvantage. The 9-month regimen can therefore be recommended as effective therapy for superficial lymph node tuberculosis.
|
Authors | |
Journal | British journal of diseases of the chest
(Br J Dis Chest)
Vol. 82
Issue 3
Pg. 282-4
(Jul 1988)
ISSN: 0007-0971 [Print] England |
PMID | 3073808
(Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Ethambutol
- Isoniazid
- Rifampin
|
Topics |
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Clinical Trials as Topic
- Drug Therapy, Combination
- Ethambutol
(administration & dosage, therapeutic use)
- Female
- Follow-Up Studies
- Humans
- Isoniazid
(administration & dosage, therapeutic use)
- Male
- Middle Aged
- Random Allocation
- Rifampin
(administration & dosage, therapeutic use)
- Tuberculosis, Lymph Node
(drug therapy)
|